Atom | Testing safety and efficacy of phage therapy for the treatment of antibiotic-resistant bacterial infections

Due Dates: September 16, 2025

Funding Amounts: ~€15,000,000 per project | 3 awards expected | Lump sum grant

Summary: Supports large, multinational clinical trials to establish the safety and efficacy of phage therapy for antibiotic-resistant bacterial infections, aiming to accelerate regulatory approval and clinical uptake.

Key Information: Proposals must include multicenter RCTs, detailed regulatory timelines, and address both personalized and ready-to-use phage therapies.

Testing safety and efficacy of phage therapy for the treatment of antibiotic-resistant bacterial infections

Sign in to see full grant listing